Standex Intl SEC Filings

Barbara Joanne Edwards, a director of Standex International Corporation (SXI), reported transactions dated 08/22/2025 under Form 4. The filing shows vesting and contingent purchase activity under the company’s Management Stock Purchase Plan: 387 shares were deemed acquired (transaction code M) at a price of $63.59, and after the reported transactions Ms. Edwards beneficially owned 5,646 common shares directly. The filing also documents phantom stock unit activity that vests and converts into common stock: 387 units related to the 08/22/2025 activity and a contingent purchase of 209 phantom units exercisable/expiring on 08/23/2028, which will result in 209 common shares when vested. The transactions reflect compensation-plan vesting rather than open-market trades.

Standex International Corporation (SXI) director Thomas J. Hansen reported transactions dated 08/22/2025 that increased his beneficial ownership. The filing shows 1,107 shares acquired through vesting of phantom stock units under the company’s Management Stock Purchase Plan at a $0 purchase price, with those units exercisable into common stock on 08/23/2025. A contingent purchase of 599 additional phantom units (to convert to common stock) was reported as vesting on 08/23/2028. The form lists a post-transaction beneficial ownership figure of 9,546.254 shares as reported on the form. The filing is signed by Alan J. Glass on 08/26/2025.

Andy L. Nemeth, a director of Standex International Corporation (SXI), purchased 2,000 shares of the issuer's common stock on 08/25/2025 at a weighted-average price of $209.4959 per share. The filing states the purchase was completed in multiple transactions at prices ranging from $209.4596 to $209.50 and that the reporting person now beneficially owns 4,500 shares. The Form 4 identifies the reporting person as a director and was filed individually. No derivative transactions or other dispositions are reported in this filing.

Robin J. Davenport, a director of Standex International Corporation (SXI), acquired 149 phantom stock units on 08/23/2025 under the Management Stock Purchase component of the companys 2018 Omnibus Incentive Plan. These units are a contingent purchase that will vest and be settled in the form of 149 shares of common stock on 08/23/2028. The reported transaction shows a conversion price of $0, and the ownership is reported as direct with 149 shares beneficially owned following the transaction. The filing indicates this award vests three years after purchase and is intended to convert to common stock at vesting.

Standex International Corporation (SXI) insider filing shows that reporting person CANNON CHARLES H JR reported a transaction dated 08/23/2025 acquiring 599 Phantom Stock Units under the company's Management Stock Purchase Plan component of the 2018 Omnibus Incentive Plan. The units were purchased as contingent phantom stock that will vest three years after the purchase date and will be settled in the form of 599 shares of Common Stock on 08/23/2028.

The report lists the securities as directly owned following the transaction, with an exercise/settlement price of $0 for the underlying common shares. The form indicates the transaction was reported on a Form 4 with an 08/23/2025 transaction date and includes a standard explanatory note describing the contingent purchase and vesting schedule.

Standex International (SXI) reported insider purchases by Max Arets, Vice President and Chief Information Officer, under the company’s Dividend Reinvestment Plan on 08/21/2025. The Form 4 shows two small acquisitions of Common Stock: 1.178 and 0.1 shares at prices of $201.6214 and $202 respectively, increasing beneficial ownership to 1,318.532 and then 1,318.632 shares (direct ownership). The filing was signed by Alan J. Glass on 08/25/2025. The filing indicates routine reinvestment of dividends rather than open-market purchases or dispositions.

Standex International Corporation (SXI) director Robin J. Davenport reported a small acquisition of common stock on 08/21/2025 under the company’s Dividend Reinvestment Plan (DRIP). The Form 4 shows an acquisition code J(1) for 1.782 shares at a reported price of $201.538 per share, resulting in 4,059.089 shares beneficially owned following the transaction.

The filing indicates the form was filed by one reporting person and lists Davenport’s relationship to the issuer as a director. The signature block shows the form was signed by Alan J. Glass on 08/25/2025. The filer states the purchase was made pursuant to the company’s DRIP; no other transactions or derivative positions are reported.

Standex International Corp. (SXI) director Thomas J. Hansen reported a sale of common stock on 08/18/2025. The filing shows 2,992 shares sold in one or more transactions at a weighted average price of $202.6049, with individual sale prices ranging from $201.045 to $203.540. After the reported sale, the filing lists 8,439.254 shares beneficially owned by the reporting person in a direct ownership form. The Form 4 is executed on behalf of the reporting person by Alan J. Glass and signed on 08/20/2025. The filer is identified as a director of the issuer, Standex International Corporation (SXI).

Form 144 notice for Standex International Corporation (SXI) reports a proposed sale of 2,992 common shares through Fidelity Brokerage Services with an aggregate market value of $606,101.92. The filing lists 12,068,262 common shares outstanding and indicates the approximate date of sale as 08/18/2025 on the NYSE. The shares to be sold were acquired through restricted stock vesting: 1,171 shares on 09/06/2022, 1,035 shares on 10/25/2021 and 786 shares on 09/06/2021, each received as compensation. The filer reports no securities sold in the past three months and includes the standard representation about absence of undisclosed material information.